NCT06024785 Vertebropexy - Randomized-controlled Trial
| NCT ID | NCT06024785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Balgrist University Hospital |
| Condition | Degeneration |
| Study Type | INTERVENTIONAL |
| Enrollment | 164 participants |
| Start Date | 2025-01-16 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 164 participants in total. It began in 2025-01-16 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess the need for additional fusion surgery versus the risk of a revision surgery in patients with degenerative lumbar spinal disease and to assess efficacy and risk of the ligamentous fixation technique (vertebropexy)
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Single-level or two-level lumbar surgery needed * Indication for decompression surgery in patients with spinal canal stenosis and additional stable degenerative listhesis (without facet joint effusion ≥ 2mm) * Indication for fusion surgery in patients with spinal canal stenosis and additional unstable degenerative listhesis (facet joint effusion ≥ 2mm), in patients with foraminal stenosis and additional degenerative listhesis, and in patients with segment degeneration of the disc * Understanding in German language Exclusion criteria: * Indication for decompression and/or fusion surgery in patients with solely disc herniation, fractures, lytic listhesis, tumor * Patients undergoing revision surgery for infection * Patients undergoing revision surgery on the same level if bony structures have been removed (e.g. prior laminectomy or midline decompression) * Patients undergoing revision surgery in case of prior fusion surgery * Inability to understand the study for linguistic or cognitive reasons * Anticipated clinical follow-up of less than 6 weeks after inclusion * Participation in other clinical trials
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06024785 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Degeneration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06024785 currently recruiting?
Yes, NCT06024785 is actively recruiting participants. Contact the research team at Mazda.Farshad@balgrist.ch for enrollment information.
Where is the NCT06024785 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT06024785 clinical trial?
NCT06024785 is sponsored by Balgrist University Hospital. The trial plans to enroll 164 participants.